Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs

One way to speed up the TB drug discovery process is to search for antitubercular activity among compound series that already possess some of the key properties needed in anti-infective drug discovery, such as whole-cell activity and oral absorption. Here, we present MGIs, a new series of Mycobacter...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Blanco, Delia, Perez-Herran, Esther, Cacho, Mónica, Ballell, Lluís, Castro, Julia, González del Río, Rubén, Lavandera, José Luis, Remuiñán, Modesto J., Richards, Cindy, Rullas, Joaquin, Vázquez-Muñiz, María Jesús, Woldu, Ermias, Zapatero-González, María Cleofé, Angulo-Barturen, Iñigo, Mendoza, Alfonso, Barros, David
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2015
Konular:
Mechanisms of Action: Physiological Effects
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356839/
https://ncbi.nlm.nih.gov/pubmed/25583730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03913-14
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller